JP5354564B2 - Medium for simultaneous detection of E. coli O26 and O157 and detection method thereof - Google Patents
Medium for simultaneous detection of E. coli O26 and O157 and detection method thereof Download PDFInfo
- Publication number
- JP5354564B2 JP5354564B2 JP2008075891A JP2008075891A JP5354564B2 JP 5354564 B2 JP5354564 B2 JP 5354564B2 JP 2008075891 A JP2008075891 A JP 2008075891A JP 2008075891 A JP2008075891 A JP 2008075891A JP 5354564 B2 JP5354564 B2 JP 5354564B2
- Authority
- JP
- Japan
- Prior art keywords
- medium
- coli
- escherichia coli
- agent
- agar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241001333951 Escherichia coli O157 Species 0.000 title claims abstract description 31
- 241000623884 Escherichia coli O26 Species 0.000 title claims abstract description 20
- 238000001514 detection method Methods 0.000 title claims description 19
- 241000588724 Escherichia coli Species 0.000 claims abstract description 33
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 33
- 239000000758 substrate Substances 0.000 claims abstract description 17
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims abstract description 12
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims abstract description 12
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000007793 ph indicator Substances 0.000 claims abstract description 10
- 235000015097 nutrients Nutrition 0.000 claims abstract description 7
- 239000007787 solid Substances 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 4
- 108090000790 Enzymes Proteins 0.000 claims description 13
- 102000004190 Enzymes Human genes 0.000 claims description 13
- 230000002378 acidificating effect Effects 0.000 claims description 9
- 230000001580 bacterial effect Effects 0.000 claims description 8
- 244000005700 microbiome Species 0.000 claims description 8
- 102000053187 Glucuronidase Human genes 0.000 claims description 7
- 108010060309 Glucuronidase Proteins 0.000 claims description 7
- 230000007935 neutral effect Effects 0.000 claims description 7
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical group C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 claims description 6
- 229960003531 phenolsulfonphthalein Drugs 0.000 claims description 6
- 239000003086 colorant Substances 0.000 claims description 5
- PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 claims description 5
- 239000003242 anti bacterial agent Substances 0.000 claims description 3
- 239000003593 chromogenic compound Substances 0.000 claims description 3
- 239000003112 inhibitor Substances 0.000 claims description 3
- SITVSCPRJNYAGV-UHFFFAOYSA-L tellurite Chemical compound [O-][Te]([O-])=O SITVSCPRJNYAGV-UHFFFAOYSA-L 0.000 claims description 3
- DHJFFLKPAYHPHU-BYNIDDHOSA-N 5-bromo-4-chloro-3-indolyl beta-D-glucuronide Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 DHJFFLKPAYHPHU-BYNIDDHOSA-N 0.000 claims description 2
- 229940088710 antibiotic agent Drugs 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 241000192125 Firmicutes Species 0.000 claims 1
- 239000001963 growth medium Substances 0.000 abstract description 5
- 230000002255 enzymatic effect Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 67
- 229920001817 Agar Polymers 0.000 description 50
- 239000008272 agar Substances 0.000 description 50
- 241000894006 Bacteria Species 0.000 description 6
- JXCKZXHCJOVIAV-UHFFFAOYSA-N 6-[(5-bromo-4-chloro-1h-indol-3-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid;cyclohexanamine Chemical compound [NH3+]C1CCCCC1.O1C(C([O-])=O)C(O)C(O)C(O)C1OC1=CNC2=CC=C(Br)C(Cl)=C12 JXCKZXHCJOVIAV-UHFFFAOYSA-N 0.000 description 5
- 239000001888 Peptone Substances 0.000 description 5
- 108010080698 Peptones Proteins 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 235000019319 peptone Nutrition 0.000 description 5
- 229960002129 cefixime Drugs 0.000 description 4
- OKBVVJOGVLARMR-QSWIMTSFSA-N cefixime Chemical compound S1C(N)=NC(C(=N\OCC(O)=O)\C(=O)N[C@@H]2C(N3C(=C(C=C)CS[C@@H]32)C(O)=O)=O)=C1 OKBVVJOGVLARMR-QSWIMTSFSA-N 0.000 description 4
- -1 5-bromo-4-chloro-3-indolyl Chemical group 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000006152 selective media Substances 0.000 description 3
- 206010061126 Escherichia infection Diseases 0.000 description 2
- 208000005577 Gastroenteritis Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 2
- 208000020612 escherichia coli infection Diseases 0.000 description 2
- BFPJYWDBBLZXOM-UHFFFAOYSA-L potassium tellurite Chemical compound [K+].[K+].[O-][Te]([O-])=O BFPJYWDBBLZXOM-UHFFFAOYSA-L 0.000 description 2
- 241000894007 species Species 0.000 description 2
- GAZVSOQUFLIBJQ-BYNIDDHOSA-N (2s,3s,4s,5r,6s)-6-[(5-bromo-6-chloro-1h-indol-3-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC1=CNC2=CC(Cl)=C(Br)C=C12 GAZVSOQUFLIBJQ-BYNIDDHOSA-N 0.000 description 1
- OYCLSQDXZMROJK-UHFFFAOYSA-N 2-bromo-4-[3-(3-bromo-4-hydroxyphenyl)-1,1-dioxo-2,1$l^{6}-benzoxathiol-3-yl]phenol Chemical compound C1=C(Br)C(O)=CC=C1C1(C=2C=C(Br)C(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 OYCLSQDXZMROJK-UHFFFAOYSA-N 0.000 description 1
- VADKRMSMGWJZCF-UHFFFAOYSA-N 2-bromophenol Chemical compound OC1=CC=CC=C1Br VADKRMSMGWJZCF-UHFFFAOYSA-N 0.000 description 1
- ZPLCXHWYPWVJDL-UHFFFAOYSA-N 4-[(4-hydroxyphenyl)methyl]-1,3-oxazolidin-2-one Chemical compound C1=CC(O)=CC=C1CC1NC(=O)OC1 ZPLCXHWYPWVJDL-UHFFFAOYSA-N 0.000 description 1
- ARQXEQLMMNGFDU-JHZZJYKESA-N 4-methylumbelliferone beta-D-glucuronide Chemical compound C1=CC=2C(C)=CC(=O)OC=2C=C1O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ARQXEQLMMNGFDU-JHZZJYKESA-N 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 241000028463 Escherichia coli O103 Species 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 208000032759 Hemolytic-Uremic Syndrome Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000003916 acid precipitation Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229940093761 bile salts Drugs 0.000 description 1
- 229960001506 brilliant green Drugs 0.000 description 1
- HXCILVUBKWANLN-UHFFFAOYSA-N brilliant green cation Chemical compound C1=CC(N(CC)CC)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](CC)CC)C=C1 HXCILVUBKWANLN-UHFFFAOYSA-N 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- WWAABJGNHFGXSJ-UHFFFAOYSA-N chlorophenol red Chemical compound C1=C(Cl)C(O)=CC=C1C1(C=2C=C(Cl)C(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 WWAABJGNHFGXSJ-UHFFFAOYSA-N 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 229940009976 deoxycholate Drugs 0.000 description 1
- 229960003964 deoxycholic acid Drugs 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- SEACYXSIPDVVMV-UHFFFAOYSA-L eosin Y Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 SEACYXSIPDVVMV-UHFFFAOYSA-L 0.000 description 1
- MKHLSGKJYGBQLI-UHFFFAOYSA-N ethoxy-(2-ethylsulfanylethylsulfanyl)-methoxy-sulfanylidene-$l^{5}-phosphane Chemical compound CCOP(=S)(OC)SCCSCC MKHLSGKJYGBQLI-UHFFFAOYSA-N 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- FDZZZRQASAIRJF-UHFFFAOYSA-M malachite green Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](C)C)C=C1 FDZZZRQASAIRJF-UHFFFAOYSA-M 0.000 description 1
- 229940107698 malachite green Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 108010009004 proteose-peptone Proteins 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940082569 selenite Drugs 0.000 description 1
- MCAHWIHFGHIESP-UHFFFAOYSA-L selenite(2-) Chemical compound [O-][Se]([O-])=O MCAHWIHFGHIESP-UHFFFAOYSA-L 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- FHHPUSMSKHSNKW-SMOYURAASA-M sodium deoxycholate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 FHHPUSMSKHSNKW-SMOYURAASA-M 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000002563 stool test Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
本発明は、食中毒菌である腸管出血性大腸菌O26およびO157を同時に分離できる培地ならびにその検出法に関するものである。 The present invention relates to a medium capable of simultaneously separating enterohemorrhagic Escherichia coli O26 and O157, which are food poisoning bacteria, and a detection method thereof.
腸管出血性大腸菌は、重篤な胃腸炎を起こし、溶血性尿毒症症候群を併発した場合は、致死的経過をとることもある病原菌であり、2006年には全国で2,154株の分離株の情報が感染症研究所に報告された。この中で、腸管出血性大腸菌O26とO157(以下、単に「O26」、「O157」と呼ぶこともある)は、それぞれ、23.8%および68.1%を占めている。厚生労働省は、近年O26による感染例の増加が目立っていることを重要視し、平成18年11月にO157だけでなく、O26も加えた腸管出血性大腸菌の食品からの検査法を通知した。この通知の中で、寒天培地は、O26用の2種類(CT-RMAC、大腸菌が鑑別できる培地)、およびO157用の2種類(CT-RMAC、O157用酵素基質培地)を用いることが原則となっているが、両方の菌を識別可能な培地があれば、3種類の培地(O26選択培地、O157選択培地、両種を選択できる培地)を用いて、O26とO157を効率よく検出することが可能となる。 Enterohemorrhagic Escherichia coli is a pathogenic bacterium that causes severe gastroenteritis and may have a lethal course if it is accompanied by hemolytic uremic syndrome. In 2006, 2,154 isolates were isolated nationwide. Information was reported to the Institute for Infectious Diseases. Among them, enterohemorrhagic Escherichia coli O26 and O157 (hereinafter sometimes simply referred to as “O26” and “O157”) account for 23.8% and 68.1%, respectively. The Ministry of Health, Labor and Welfare emphasized that the number of cases of infection caused by O26 has been conspicuous in recent years. In November 2006, the Ministry of Health, Labor and Welfare notified the inspection method for enterohemorrhagic Escherichia coli not only O157 but also O26. In this notice, as a rule, two types of agar medium for O26 (CT-RMAC, medium that can distinguish E. coli) and two types for O157 (CT-RMAC, enzyme substrate medium for O157) should be used. However, if there is a medium that can distinguish both types of bacteria, O26 and O157 should be detected efficiently using three types of medium (O26 selection medium, O157 selection medium, medium that can select both types). Is possible.
また、胃腸炎患者や調理従事者の糞便検査における腸管出血性大腸菌の対象は、多くの場合、O157に絞り込んで実施しているのが現状であるが、O26とO157が識別できる培地が開発されれば、労力や経費を増すことなく、O26も対象とすることができ、腸管出血性大腸菌感染症の検出効率を上げることが可能となる。 In addition, enterohaemorrhagic Escherichia coli targets in stool tests for gastroenteritis patients and cooking workers are currently being narrowed down to O157, but a medium that can distinguish O26 and O157 has been developed. Therefore, O26 can be targeted without increasing labor and cost, and the detection efficiency of enterohemorrhagic Escherichia coli infection can be increased.
現在、腸管出血性大腸菌O26と一般の大腸菌、あるいはO157と一般の大腸菌を検出するための培地は数種類製品化されており、特許出願や論文も多数認められる(特許文献、非特許文献)。
従って、食品や糞便等の検体からO26とO157の両方の大腸菌を選択的に分離するためには、最低2種類の寒天培地が必要となる。
なお、O26用としてはCT-RMAC寒天培地(デンカ生研等)とCT-RX O26寒天培地(栄研化学)が、O157用としてはCT-SMAC寒天培地(日水製薬等)、BCMO157寒天培地(栄研化学)、クロモアガーO157培地(クロモアガー)、CT-O157:H7ID寒天培地(日本ビオメリュー)等が製品化されている。
At present, several types of media for detecting enterohemorrhagic E. coli O26 and general E. coli, or O157 and general E. coli have been commercialized, and many patent applications and papers are recognized (patent documents and non-patent documents).
Therefore, in order to selectively separate both O26 and O157 E. coli from samples such as food and feces, at least two types of agar medium are required.
For O26, CT-RMAC agar medium (Denka Seika etc.) and CT-RX O26 agar medium (Eiken Chemical), for O157 CT-SMAC agar medium (Nissui Pharmaceutical etc.), BCMO157 agar medium ( Eiken Chemical Co., Ltd.), chromoagar O157 medium (chromoager), CT-O157: H7ID agar medium (Nihon Biomeryu), etc. have been commercialized.
O26用の培地は、O26が一般の大腸菌と異なりラムノース(糖の一種)非分解である性質を利用しており、O157用の培地の多くは、O157のソルビトール(糖の一種)非分解あるいはβ-グルクロニダーゼ活性陰性の性質を利用したものであり、これらはO26とO157のいずれか一方は検出可能であるが、他方と一般大腸菌を区別することはできない。
このような技術の現状に鑑み、O26とO157および一般の大腸菌を同時に識別できる培地ならびにその検出法を開発することである。 In view of the current state of the art, it is to develop a medium capable of simultaneously distinguishing O26 and O157 and general E. coli and a detection method thereof.
すなわち請求項1記載の大腸菌O26およびO157同時検出培地は、栄養素、鑑別剤、選択剤および固形剤からなる培地において、鑑別剤としてラムノース、大腸菌O157が非発色の酵素基質および中性色と酸性色が異なるpH指示薬を含有し、かつ、選択剤としてO26とO157以外の大腸菌や大腸菌以外の細菌微生物の生育を抑制するものを含有することを特徴として成るものである。 That is, the Escherichia coli O26 and O157 simultaneous detection medium according to claim 1 is a medium comprising nutrients, a discrimination agent, a selection agent, and a solid agent. As a discrimination agent, rhamnose, Escherichia coli O157 is a non-chromogenic enzyme substrate and neutral and acidic colors. Is characterized in that it contains different pH indicators and contains as a selective agent what inhibits the growth of E. coli other than O26 and O157 and bacterial microorganisms other than E. coli .
また請求項2記載の大腸菌O26およびO157同時検出培地は、前記請求項1記載の要件に加え、選択剤としてO26とO157以外の大腸菌や大腸菌以外の細菌微生物の生育を抑制するものは、グラム陽性菌抑制剤、亜テルル酸塩および抗生物質から選ばれた一種または2種以上を含有することを特徴として成るものである。 Furthermore, the Escherichia coli O26 and O157 simultaneous detection medium according to claim 2 is a Gram-positive medium that suppresses the growth of Escherichia coli other than O26 and O157 and bacterial microorganisms other than Escherichia coli as a selective agent in addition to the requirement of claim 1 above. It is characterized by containing one or more selected from among fungus inhibitors, tellurite and antibiotics.
また請求項3記載の大腸菌O26およびO157同時検出培地は、前記請求項1または2記載の要件に加え、中性色と酸性色が異なるpH指示薬がフェノールレッドあるいはニュートラルレッドであることを特徴として成るものである。 Further, the Escherichia coli O26 and O157 simultaneous detection medium according to claim 3 is characterized in that, in addition to the requirement according to claim 1 or 2, the pH indicator having a neutral color and an acidic color is phenol red or neutral red. Is.
また請求項4記載の大腸菌O26およびO157同時検出培地は、前記請求項1、2または3記載の要件に加え、大腸菌O157が非発色の酵素基質がβ―グルクロニダーゼの基質である色原体化合物であることを特徴として成るものである。 The E. coli O26 and O157 simultaneous detection medium according to claim 4 is a chromogenic compound in which E. coli O157 is a non-chromogenic enzyme substrate is a β-glucuronidase substrate in addition to the requirements of claim 1, 2 or 3. It is characterized by being.
また請求項5記載の大腸菌O26およびO157同時検出培地は、前記請求項1、2、3または4記載の要件に加え、大腸菌O157が非発色の酵素基質が5−ブロモ―4−クロロー3−インドリルーβ―D−グルクロニドであることを特徴として成るものである。Further, the Escherichia coli O26 and O157 simultaneous detection medium according to claim 5 is characterized in that, in addition to the requirement of claim 1, 2, 3 or 4, E. coli O157 is non-chromogenic enzyme substrate is 5-bromo-4-chloro-3-indolyl It is characterized by being β-D-glucuronide.
また請求項6記載の大腸菌O26およびO157同時検出法は、栄養素、鑑別剤、選択剤および固形剤からなる培地において鑑別剤としてラムノース、大腸菌O157が非発色の酵素基質および中性色と酸性色が異なるpH指示薬を含有し、かつ、選択剤としてO26とO157以外の大腸菌や大腸菌以外の細菌微生物の生育を抑制するものを含有する培地を用いることを特徴として成るものである。 The method for simultaneous detection of Escherichia coli O26 and O157 according to claim 6 is such that rhamnose and Escherichia coli O157 are non-chromogenic enzyme substrates and neutral and acidic colors as a distinguishing agent in a medium comprising nutrients, a distinguishing agent, a selective agent and a solid agent. It is characterized by using a medium containing different pH indicators and containing as a selective agent what suppresses the growth of E. coli other than O26 and O157 and bacterial microorganisms other than E. coli .
本願発明によればO26とO157が同時に識別できることから、労力や経費を増すことなく、更にO26の識別することができるので腸管出血性大腸菌感染症の検出効率を上げることが可能となる。 According to the present invention, since O26 and O157 can be identified simultaneously, O26 can be further identified without increasing labor and cost, so that the detection efficiency of enterohemorrhagic Escherichia coli infection can be increased.
本発明者は、栄養素、鑑別剤、選択剤および固形剤からなる培地において、鑑別剤としてラムノース、大腸菌O157が非発色の酵素基質およびpH指示薬を用いると、O26とO157および一般の大腸菌を識別できることを見出し、鋭意、検討の結果、大腸菌O26およびO157を同時に検出することができる分離用培地ならびにその検出法を完成した。 The present inventor is able to distinguish between O26 and O157 and general E. coli when using rhamnose, E. coli O157 non-chromogenic enzyme substrate and pH indicator as a discrimination agent in a medium composed of nutrients, discrimination agents, selection agents and solid agents. As a result of intensive research and examination, a separation medium capable of simultaneously detecting E. coli O26 and O157 and a detection method thereof were completed.
本発明の培地に用いられる栄養素としては、微生物の発育に必要な成分はいずれも用いることができ、カゼインペプトン、獣肉ペプトン、大豆ペプトン、ゼラチンペプトン、カゼイン・獣肉ペプトンなどのペプトン、肉エキス、心臓浸出液、酵母エキス、麦芽エキス、ジャガイモエキスなどのエキス、塩化ナトリウム、リン酸水素二カリウムなどの無機塩類を用いることができる。 As the nutrient used in the medium of the present invention, any component necessary for the growth of microorganisms can be used. Casein peptone, animal meat peptone, soybean peptone, gelatin peptone, casein / animal meat peptone, etc., meat extract, heart Extracts such as leachate, yeast extract, malt extract, and potato extract, and inorganic salts such as sodium chloride and dipotassium hydrogen phosphate can be used.
本発明の培地においては、鑑別剤としてラムノースと大腸菌O157が非発色の酵素基質ならびにpH指示薬を用いる。
大腸菌O157が非発色の酵素基質としては、β―グルクロニダーゼの基質である色原体化合物であって、例えば、X-Gluc:5-ブロモ−4−クロロ−3−インドリル-β-D-グルクロニド、MUG: 4−メチルウンベリフェリル-β-D-グルクロニド、Magenta-Gluc: 5-ブロモ-6-クロロ-3-インドリル-β-D-グルクロニド、Salmon-Gluc: 6-クロロ-3-インドリル-β-D-グルクロニドなどが用いられる。これらは、培地1リットルあたり0.05〜0.5g程度使用するのが良い。
In the medium of the present invention, rhamnose and Escherichia coli O157 are non-chromogenic enzyme substrates and pH indicators are used as a discrimination agent.
The non-chromogenic enzyme substrate of E. coli O157 is a chromogenic compound that is a substrate of β-glucuronidase, for example, X-Gluc: 5-bromo-4-chloro-3-indolyl-β-D-glucuronide, MUG: 4-methylumbelliferyl-β-D-glucuronide, Magenta-Gluc: 5-bromo-6-chloro-3-indolyl-β-D-glucuronide, Salmon-Gluc: 6-chloro-3-indolyl-β -D-glucuronide and the like are used. These are preferably used in an amount of about 0.05 to 0.5 g per liter of medium.
pH指示薬としては、フェノールレッド、ニュートラルレッド、ブロモフェノールパープル、ブロモチモールブルー、ブロモフェノールレッド、クロロフェノールレッドなどの中性色と酸性色が異なる指示薬が適している。これらは、用いる指示薬により異なるが、培地1リットルあたり0.01〜0.1g程度使用するのが良い。 As the pH indicator, indicators having different neutral and acidic colors such as phenol red, neutral red, bromophenol purple, bromothymol blue, bromophenol red, and chlorophenol red are suitable. Although these differ depending on the indicator used, it is preferable to use about 0.01 to 0.1 g per liter of the medium.
選択剤としては、O26とO157以外の大腸菌や大腸菌以外の細菌微生物の生育を抑制するものが用いられる。例えば、胆汁酸塩、デスオキシコール酸ナトリウム、ラウリル酸ナトリウム等の界面活性剤、クエン酸ナトリウム等の有機酸塩、エオジンY、メチレンブルー、ブリリアントグリーン、クリスタルバイオレット、マラカイトグリーン等の色素、セレナイト、テトラチオン酸塩、チオ硫酸ナトリウム等の無機塩類、亜テルル酸塩、セフィキシムなどの抗菌剤等を必要に応じて使用することができる。これらは、用いる選択剤により異なるが、培地1リットルあたり0.0001〜2g程度使用するのが良い。 As the selective agent, one that suppresses the growth of E. coli other than O26 and O157 and bacterial microorganisms other than E. coli is used. For example, surfactants such as bile salts, sodium desoxycholate and sodium laurate, organic acid salts such as sodium citrate, pigments such as eosin Y, methylene blue, brilliant green, crystal violet, malachite green, selenite, tetrathion Inorganic salts such as acid salts and sodium thiosulfate, and antibacterial agents such as tellurite and cefixime can be used as necessary. These differ depending on the selection agent used, but it is better to use about 0.0001 to 2 g per liter of the medium.
固形剤としては、寒天がもっとも便利に用いられる。
以下、実施例に基づき本発明を更に詳細に説明するが、本発明を何ら限定するものではない。
As a solid agent, agar is most conveniently used.
EXAMPLES Hereinafter, although this invention is demonstrated further in detail based on an Example, this invention is not limited at all.
本発明の培地であるデオキシコレート・ラムノース・X-Gluc寒天培地(DRX寒天培地)、セフィキシム・亜テルル酸カリウム加DRX寒天培地(CT-DRX寒天培地)および胆汁酸・ラムノース・X-Gluc寒天培地(BRX寒天培地)を作製した。各培地の組成に精製水を加え全量を1000mlとし、加温溶解後、50〜60℃に冷却し、シャーレに20mlずつ分注した。なお、セフィキシムと亜テルル酸カリウムは、50〜60℃に冷却後に添加した。 Deoxycholate / rhamnose / X-Gluc agar (DRX agar), cefixime / potassium tellurite-added DRX agar (CT-DRX agar) and bile acids / rhamnose / X-Gluc agar (BRX agar medium) was prepared. Purified water was added to the composition of each medium to make a total volume of 1000 ml, heated and dissolved, cooled to 50-60 ° C., and dispensed into a petri dish at 20 ml. Cefixime and potassium tellurite were added after cooling to 50-60 ° C.
腸管出血性大腸菌O26分離株(S4433)、腸管出血性大腸菌O157分離株(S4099)および一般の大腸菌O103分離株(S5163)の菌液をDRX寒天培地、CT-DRX寒天培地およびBRX寒天培地に画線塗抹し、37℃で20時間培養後、各培地に発育した集落を観察した。 Intestinal hemorrhagic Escherichia coli O26 isolate (S4433), enterohemorrhagic Escherichia coli O157 isolate (S4099) and general E. coli O103 isolate (S5163) were collected on DRX agar, CT-DRX agar and BRX agar. After colonizing and culturing at 37 ° C. for 20 hours, colonies that grew on each medium were observed.
表4に示したようにDRX寒天培地上の集落は、O26はラムノース非分解であるのでペプトン等の分解物によりアルカリ性に傾きフェノールレッドが赤色になり、さらにβ−グルクロニダーゼ活性により発色酵素基質(X-Gluc)が青緑色に発色し、混合され青色になった。O157は本培地の条件下ではラムノース弱分解でありフェノールレッドはほぼ培地色にとどまり、β−グルクロニダーゼ活性も陰性であるので、透明感のある白色集落となった。O103は、ラムノースを分解することにより酸性に傾き、フェノールレッドの黄変とデオキシコール酸析出により混濁した淡黄色になり、さらにβ−グルクロニダーゼ活性により青緑色に発色することで、結果として混濁した緑色になった。 As shown in Table 4, in the colonies on DRX agar medium, O26 is not rhamnose-degraded, so it decomposes to alkaline due to degradation products such as peptone, and the phenol red turns red. Furthermore, the β-glucuronidase activity causes the chromogenic enzyme substrate (X -Gluc) turned blue-green and mixed to turn blue. O157 was weakly rhamnose-degraded under the conditions of this medium, phenol red remained almost the medium color, and β-glucuronidase activity was negative, so a transparent white colony was formed. O103 tends to be acidic by decomposing rhamnose, turns pale yellow due to yellowing of phenol red and deoxycholic acid precipitation, and further turns blue-green due to β-glucuronidase activity, resulting in a turbid green color. Became.
O26とO157以外の細菌に対する抑制力を強化したCT-DRX寒天培地では、O26とO157はDRX寒天培地と同様の集落を形成したが、O103は発育することができなかった。
BRX寒天培地では、O26はX-Glucの発色(青緑色)とアルカリ性による淡黄色(ニュートラルレッドのアルカリ色)で緑色の集落となり、O157はβ−グルクロニダーゼ活性陰性であり、ラムノース分解性も弱いのでやや赤みを帯びた白色集落(透明)となった。O103はラムノース分解による赤色化(ニュートラルレッドの酸性色)とX-Glucの発色(青緑色)が混合され紫色の集落となった。
3種類の大腸菌を混合して塗抹した場合は、DRX寒天培地とBRX寒天培地では3色の集落が混在していたが、CT-DRX寒天培地ではO103の発育がみられないので2色の集落しか確認できなかった。
In CT-DRX agar medium with enhanced inhibitory power against bacteria other than O26 and O157, O26 and O157 formed colonies similar to DRX agar medium, but O103 could not grow.
On the BRX agar medium, O26 is a green colony with X-Gluc color (blue green) and alkaline pale yellow (neutral red alkali color). It became a slightly reddish white village (transparent). O103 was mixed with reddish color due to rhamnose decomposition (neutral red acidic color) and X-Gluc color (blue-green), resulting in a purple colony.
When three types of E. coli were mixed and smeared, the DRX agar medium and the BRX agar medium had three color colonies, but the CT-DRX agar medium did not show O103 growth, so the two color colonies I could only confirm.
実施例1で作成したDRX寒天培地とCT-DRX寒天培地における大腸菌の発育状況と集落色を平成18年11月2日付け食安監発第1102004号指定のCT-RMAC寒天培地、CT-SMAC寒天培地、CT-RXO26寒天培地およびクロモアガーO157TAM寒天培地と比較した。O26、O157およびその他の大腸菌の各6株の菌液をPBS(-)で、10−8まで10倍段階希釈し、50μlずつ各選択培地およびハートインヒュージョン(HI)寒天培地に塗抹し、37℃で20時間培養後、集落色の確認と集落数の測定を行った。なお、かっこ内の数字は、HI寒天培地で測定した菌数を100とした場合の各培地での細菌数を示す。 The growth status and colony color of E. coli on DRX agar medium and CT-DRX agar medium prepared in Example 1 were designated as CT-RMAC agar medium and CT-SMAC agar designated by No. 1102004 on November 2, 2006. The culture medium, CT-RXO26 agar medium and chromoagar O157TAM agar medium were compared. The bacterial solution of each of the 6 strains of O26, O157 and other E. coli was diluted 10-fold with PBS (-) to 10-8, and 50 μl was smeared on each selective medium and heart infusion (HI) agar medium. After culturing at 20 ° C. for 20 hours, confirmation of settlement color and measurement of the number of settlements were performed. The numbers in parentheses indicate the number of bacteria in each medium when the number of bacteria measured on the HI agar medium is 100.
表5に示したようにDRX寒天培地およびCT-DRX寒天培地上の集落は、O26の6株すべてが青色に、O157の6株すべてが白色になった。また、O26株はすべてO26用の選択培地であるCT-RMAC寒天培地とCT-RXO26寒天培地に、O157株はすべてO157用のCT-SMAC寒天培地とクロモアガーO157TAM寒天培地に発育し、集落色もすべて各培地が設定した色になった。O26、O157以外の大腸菌は、DRX寒天培地では6株とも緑色集落となったが、CT-DRX寒天培地では、6株中4株が他のセフィキシムと亜テルル酸カリウム添加培地(CT-SMAC寒天培地、CT-RXO26寒天培地)と同様に発育がみられなかった。DRXおよびCT-DRX寒天培地におけるO26株とO157株の発育菌数は、抑制剤などの影響でHI寒天培地に比べやや少なくなる傾向がみられたが、他の選択培地と比べると個々の菌株では多少増減がみられるものの発育菌数に大きな違いはみられなかった。 As shown in Table 5, in the colonies on DRX agar medium and CT-DRX agar medium, all 6 strains of O26 turned blue and all 6 strains of O157 turned white. In addition, all O26 strains grow on CT-RMAC agar and CT-RXO26 agar, which are selective media for O26, and all O157 strains grow on CT-SMAC agar and chromoagar O157TAM agar for O157. All of the media became the set colors. E. coli other than O26 and O157 showed green colonies in 6 strains on the DRX agar medium, but 4 out of 6 strains on the CT-DRX agar medium were supplemented with other cefixime and potassium tellurite (CT-SMAC agar). Growth was not observed as in the case of the medium, CT-RXO26 agar medium). The number of O26 and O157 strains grown on DRX and CT-DRX agar media tended to be slightly lower than that on HI agar media due to the effects of inhibitors, but individual strains compared to other selective media However, although there was some increase or decrease, there was no significant difference in the number of growing bacteria.
大腸菌以外の主な腸内細菌科の6菌種をDRX寒天培地とCT-DRX寒天培地に画線塗抹し、37℃で20時間培養し、発育集落を観察した。 Six strains of major enterobacteriaceae other than E. coli were streaked on DRX agar medium and CT-DRX agar medium, cultured at 37 ° C. for 20 hours, and the growth colonies were observed.
表6に示したようにこれら6菌種の中でDRX寒天培地とCT-DRX寒天培地上でO26と同様の青色集落を形成するものはなかった。Proteus属の2菌種はDRX寒天培地ではO157に類似した白色(透明)の集落となったが、CT-DRX寒天培地では非発育あるいは微小集落となり、O157の集落との識別は可能であった。 As shown in Table 6, none of these six species formed a blue colony similar to O26 on DRX agar medium and CT-DRX agar medium. Two species of the genus Proteus were white (transparent) colonies similar to O157 on DRX agar medium, but became non-developed or microcolonized on CT-DRX agar medium and could be distinguished from O157 colonies. .
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008075891A JP5354564B2 (en) | 2008-03-24 | 2008-03-24 | Medium for simultaneous detection of E. coli O26 and O157 and detection method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008075891A JP5354564B2 (en) | 2008-03-24 | 2008-03-24 | Medium for simultaneous detection of E. coli O26 and O157 and detection method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009225729A JP2009225729A (en) | 2009-10-08 |
| JP5354564B2 true JP5354564B2 (en) | 2013-11-27 |
Family
ID=41241894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008075891A Expired - Fee Related JP5354564B2 (en) | 2008-03-24 | 2008-03-24 | Medium for simultaneous detection of E. coli O26 and O157 and detection method thereof |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5354564B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019024418A (en) * | 2017-07-31 | 2019-02-21 | 公立大学法人大阪府立大学 | Selective separation medium |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2747394B1 (en) * | 1996-04-15 | 1998-07-03 | Rambach Alain | CULTURE MEDIUM FOR THE EVIDENCE OF ENTEROHEMORRAGIC E. BACTERIA BACTERIA, AND METHOD FOR ITS EVIDENCE |
| JP3026005B1 (en) * | 1999-01-26 | 2000-03-27 | 愛知県 | Development of rhamno-smacconkey (RMAC) medium and rhamno-smacconkey (CT-RMAC) medium supplemented with cefixime potassium potassium tellurite, which are selective separation media for enterohemorrhagic Escherichia coli O26 |
| JP4334067B2 (en) * | 1999-06-30 | 2009-09-16 | 栄研化学株式会社 | E. coli O26 separation medium |
| JP4472078B2 (en) * | 1999-12-20 | 2010-06-02 | 三菱化学メディエンス株式会社 | Bacteria isolation / detection method |
| JP4196318B2 (en) * | 2002-02-13 | 2008-12-17 | 関東化学株式会社 | Selective separation medium for E. coli and separation method |
| JP4331582B2 (en) * | 2003-12-17 | 2009-09-16 | 日水製薬株式会社 | Method for detecting E. coli and / or coliforms |
-
2008
- 2008-03-24 JP JP2008075891A patent/JP5354564B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009225729A (en) | 2009-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Manafi | New developments in chromogenic and fluorogenic culture media | |
| Merlino et al. | Evaluation of CHROMagar Orientation for differentiation and presumptive identification of gram-negative bacilli and Enterococcus species | |
| JP5911511B2 (en) | Articles and methods for detecting target microorganisms | |
| US6136554A (en) | Microbiological media for isolation and indentification of enteric pathogens such as E. coli and salmonella | |
| Van Kregten et al. | New, simple medium for selective recovery of Klebsiella pneumoniae and Klebsiella oxytoca from human feces | |
| Frampton et al. | Evaluation of the β-glucuronidase substrate 5-bromo-4-chloro-3-indolyl-β-D-glucuronide (X-GLUC) in a 24-hour direct plating method for Escherichia coli | |
| US8883441B2 (en) | Method for detecting and counting micro-organisms in a sample | |
| US8216802B2 (en) | Detection medium for gram negative bacteria | |
| WO2004063392A2 (en) | Selective culture medium for the isolation and/or detection of species in the streptococcus genus | |
| JP6387229B2 (en) | Enterohemorrhagic Escherichia coli detection medium | |
| JP4334067B2 (en) | E. coli O26 separation medium | |
| CN103820373B (en) | Chromogenic culture medium for separating and detecting enterobacter cloacae | |
| Chen et al. | Evaluation of a revised US Food and Drug Administration method for the detection and isolation of Enterobacter sakazakii in powdered infant formula: precollaborative study | |
| JP5354564B2 (en) | Medium for simultaneous detection of E. coli O26 and O157 and detection method thereof | |
| CN105861623B (en) | Chromogenic culture medium for detecting enterobacter sakazakii | |
| CN103725746A (en) | Coli group and colibacillus testing medium | |
| RU2425877C1 (en) | BACTERIOPHAGE Escherichia coli V32 STRAIN FOR IDENTIFICATION OF Escherichia coli BACTERIA SEROGROUP O157 | |
| JP5011104B2 (en) | Test medium | |
| JP5639791B2 (en) | Medium for detection of E. coli in foods and drinks containing β-glucuronidase | |
| US9593358B2 (en) | Method and medium for detecting Shiga toxin-producing Escherichia coli bacteria | |
| CN115896231B (en) | A method for detecting and isolating foodborne pathogenic Aeromonas | |
| US10233477B2 (en) | Culture medium for microorganisms including para-aminobenzoic acid as a selective agent | |
| JP6124912B2 (en) | Medium and method for detecting pathogenic Yersinia enterocolitica bacteria | |
| JP5826005B2 (en) | Enterohemorrhagic Escherichia coli detection medium | |
| Manchanda et al. | Case repot-liver abscess caused by Edwardsiella tarda biogroup 1 and identification of its epidemiological triad by ribotyping |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110311 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130326 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130527 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20130527 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130730 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130821 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |